Cargando…

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is characterized by an important heterogeneity, reflected by different clinical outcomes and chemoresistance. During carcinogenesis, tumor cells display aberrant glycosylated structures, synthetized by deregulated glycosyltransferases, supporting t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed Abd-El-Halim, Yousra, El Kaoutari, Abdessamad, Silvy, Françoise, Rubis, Marion, Bigonnet, Martin, Roques, Julie, Cros, Jérôme, Nicolle, Rémy, Iovanna, Juan, Dusetti, Nelson, Mas, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379629/ https://www.ncbi.nlm.nih.gov/pubmed/34425307 http://dx.doi.org/10.1016/j.ebiom.2021.103541

Ejemplares similares

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers
por: El Kaoutari, Abdessamad, et al.
Publicado: (2023)

Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models
por: Hoare, Owen, et al.
Publicado: (2021)

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
por: Bian, Benjamin, et al.
Publicado: (2019)

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021)

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
por: Nicolle, Rémy, et al.
Publicado: (2020)

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022)

Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2018)

Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2020)

Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer
por: Nicolle, R., et al.
Publicado: (2021)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
por: Turpin, Anthony, et al.
Publicado: (2022)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2023)

Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
por: Masoud, Rawand, et al.
Publicado: (2020)

Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
por: Bian, Benjamin, et al.
Publicado: (2017)

A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT
por: Barraud, Marine, et al.
Publicado: (2016)

E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments
por: Lan, Wenjun, et al.
Publicado: (2018)

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
por: Olivares, Orianne, et al.
Publicado: (2017)

Development and Validation of a Microarray for the Investigation of the CAZymes Encoded by the Human Gut Microbiome
por: El Kaoutari, Abdessamad, et al.
Publicado: (2013)

TNF-α induces endothelial–mesenchymal transition promoting stromal development of pancreatic adenocarcinoma
por: Adjuto-Saccone, Marjorie, et al.
Publicado: (2021)

LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma
por: Acier, Angélina, et al.
Publicado: (2021)

Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features
por: Raffenne, Jérôme, et al.
Publicado: (2021)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Repurposing Avasimibe to Inhibit Bacterial Glycosyltransferases
por: Hasan, Md Kamrul, et al.
Publicado: (2022)

Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights
por: Mas, Léo, et al.
Publicado: (2021)

A Metagenomics Investigation of Carbohydrate-Active Enzymes along the Gastrointestinal Tract of Saudi Sheep
por: Al-Masaudi, Saad, et al.
Publicado: (2017)

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
por: Nicolle, Rémy, et al.
Publicado: (2017)

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019)

Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset
por: Nicolle, Remy, et al.
Publicado: (2019)

Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells
por: Boudouresque, Françoise, et al.
Publicado: (2018)

High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors
por: El Qaidi, Samir, et al.
Publicado: (2018)

Membrane Topological Model of Glycosyltransferases of the GT-C Superfamily
por: Albuquerque-Wendt, Andreia, et al.
Publicado: (2019)

hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status
por: Raffenne, Jerome, et al.
Publicado: (2019)

Effector Glycosyltransferases in Legionella
por: Belyi, Yury, et al.
Publicado: (2011)

Higher plant glycosyltransferases
por: Ross, Joe, et al.
Publicado: (2001)

Processivity in Bacterial Glycosyltransferases
por: Yakovlieva, Liubov, et al.
Publicado: (2019)

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2023)

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment
por: Foucher, Etienne D., et al.
Publicado: (2018)

Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers
por: Martinez, Emmanuelle, et al.
Publicado: (2015)

Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma
por: Saillard, Charlie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e8m53ugpms6dr6en8np77osbgl